Company: CERO
Filing Date: 2025-08-11
Form Type: S-3
Source: 0001213900-25-073849
Chunk: 28

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-11
Form: S-3
Chunk 28
---
 we refer you to the
registration statement, including the exhibits filed as a part of the registration statement. Statements contained in this prospectus
concerning the contents of any contract or document referred to are not necessarily complete. If a contract or document has been filed
as an exhibit to the registration statement, please see the copy of the contract or document that has been filed. Each statement in this
prospectus relating to a contract or document filed as an exhibit is qualified in all respects by the filed exhibit.

In addition, we file annual,
quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public on a website
maintained by the SEC located at www.sec.gov.We also maintain a website at www.cero.bio/investors.Through our website,
we make available, free of charge, annual, quarterly and current reports, proxy statements and other information as soon as reasonably
practicable after they are electronically filed with, or furnished to, the SEC. The information contained on, or that may be accessed
through, our website is not part of, and is not incorporated into, this prospectus. Information contained on our website is not a part
of or incorporated by reference into this prospectus and the inclusion of our website and investor relations website addresses in this
prospectus is an inactive textual reference only.

<div align='center'>13

INCORPORATION OF DOCUMENTS BY REFERENCE</div>

The SEC allows us to incorporate
by reference into this prospectus the information contained in other documents we file with the SEC, which means that we can disclose
important information to you by referring you to those documents. Any statement contained in any document incorporated or deemed to be
incorporated by reference herein shall be deemed to be modified or superseded, for purposes of this prospectus, to the extent that a statement
contained in or omitted from this prospectus, or in any other subsequently filed document that also is or is deemed to be incorporated
by reference herein, modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as
so modified or superseded, to constitute a part of this prospectus. We incorporate by reference the documents listed below which have
been filed by us:

All documents we file with
the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, except as to any portion of any report or documents